---
title: "YOU: Q2 2026 revenue up 26.6%, net income $72.3M, and free cash flow guidance raised to $480M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294946958.md"
description: "Revenue grew 26.6% year-over-year to $277.8 million in Q2 2026, with net income of $72.3 million and a 36.4% Adjusted EBITDA margin. Membership and network expansion drove strong results, and full-year free cash flow guidance was raised to at least $480 million.Original document: Clear Secure, Inc. [YOU] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T10:10:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294946958.md)
  - [en](https://longbridge.com/en/news/294946958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294946958.md)
generator: "portal-rs"
---

# YOU: Q2 2026 revenue up 26.6%, net income $72.3M, and free cash flow guidance raised to $480M

Revenue grew 26.6% year-over-year to $277.8 million in Q2 2026, with net income of $72.3 million and a 36.4% Adjusted EBITDA margin. Membership and network expansion drove strong results, and full-year free cash flow guidance was raised to at least $480 million.

Original document: Clear Secure, Inc. \[YOU\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [YOU.US](https://longbridge.com/en/quote/YOU.US.md)

## Related News & Research

- [08:20 ETHealthy Together and CLEAR Partner to Help States Prevent Medicaid Fraud](https://longbridge.com/en/news/296105107.md)
- [Abacus FCF Advisors LLC Purchases New Stake in CLEAR Secure, Inc. $YOU](https://longbridge.com/en/news/296448699.md)
- [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**